Nano Flow

Executive Summary

Nano Flow is a Belgian company established in 2015 as a specialized branch of Unisensor, with over 25 years of diagnostic engineering experience. It has positioned itself as Europe's leading supplier of gold nanoparticles for rapid diagnostic tests, particularly lateral flow assays. The company's core competitive advantage lies in its unique, automated manufacturing process that produces highly spherical gold colloids and antibody conjugates, enhancing the sensitivity and reliability of diagnostic tests. By focusing on the quality and uniformity of nanoparticles, Nano Flow aims to improve the performance of rapid tests used in various applications, including infectious disease detection, pregnancy testing, and cardiac marker analysis. The company serves a growing market driven by the demand for decentralized, point-of-care diagnostics. As a private company with a niche but critical role in the diagnostics supply chain, Nano Flow is strategically positioned to benefit from the expansion of rapid testing and the increasing emphasis on test accuracy. Its proprietary manufacturing process provides a differentiation that could enable partnerships with leading diagnostic kit manufacturers. The company's potential for growth is tied to the broader trends in healthcare decentralization and the need for reliable, rapid diagnostics. While the company operates in a competitive landscape with established players, its technological edge and the backing of Unisensor's expertise provide a foundation for capturing market share. Future success will depend on scaling production, expanding into new diagnostic segments, and securing collaborations with major diagnostic companies.

Upcoming Catalysts (preview)

• Q4 2026Launch of High-Sensitivity Nanoparticle Line for Molecular Diagnostics60% success
• Q2 2026Strategic Partnership with a Top-Tier Point-of-Care Diagnostics Firm70% success
• Q3 2026Expansion into US Market with Local Distribution or Manufacturing50% success